Literature DB >> 12064793

Up-regulation of CD11a (LFA-1) expression on peripheral CD4+ T cells in primary biliary cirrhosis.

Masaaki Shiina1, Koju Kobayashi, Yutaka Mano, Yoshiyuki Ueno, Motoyasu Ishii, Tooru Shimosegawa.   

Abstract

Up-regulation of CD11a expression on CD4+ T lymphocytes is considered to be one of the mechanisms involved in the initiation of the Th-1-mediated immune response. In this study, peripheral blood mononuclear cells from patients with primary biliary cirrhosis (PBC) were evaluated for CD11a(high) CD2(low) T cells and populations of type 1 (Th-1) and type 2 (Th-2) helper T cells. CD11a(high) CD2(low) T cells were found in PBC (7/15) and in active rheumatoid arthritis (4/4), but not in chronic hepatitis C (0/5) or in healthy subjects (0/6). The population of Th-1 had a positive correlation with that of CD4+ CD11a(high) CD2+ cells in patients with PBC (P = 0.034). The serum levels of interferon-gamma also had a weak correlation with the population of CD4+ CD11a(high) CD2(low) cells (P = 0.050). There was no statistically significant correlation of Th-2 population (P = 0.295) or serum interleukin-4 level (P = 0.685) with the population of CD4+ CD11a(high) CD2(low) cells. These results suggest that CD4+ CD11a(high) cells play a role in Th-1-predominance and in the autoimmune process of PBC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12064793     DOI: 10.1023/a:1015345825025

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

Review 1.  T-cell subsets (Th1 versus Th2).

Authors:  S Romagnani
Journal:  Ann Allergy Asthma Immunol       Date:  2000-07       Impact factor: 6.347

2.  Progressive development of a Th1-type hepatic cytokine profile in rats with experimental cholangitis.

Authors:  K Tjandra; K A Sharkey; M G Swain
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

Review 3.  Acquisition of immunologic self-tolerance.

Authors:  R H Schwartz
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

Review 4.  Cytokines in primary biliary cirrhosis.

Authors:  P A Berg; R Klein; M Röcken
Journal:  Semin Liver Dis       Date:  1997-05       Impact factor: 6.115

Review 5.  Ludwig Symposium on biliary disorders--part II. Pathologic features and evolution of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  P J Scheuer
Journal:  Mayo Clin Proc       Date:  1998-02       Impact factor: 7.616

6.  Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry.

Authors:  B Berner; D Akça; T Jung; G A Muller; M A Reuss-Borst
Journal:  J Rheumatol       Date:  2000-05       Impact factor: 4.666

7.  In situ nucleic acid hybridization of cytokines in primary biliary cirrhosis: predominance of the Th1 subset.

Authors:  K Harada; J Van de Water; P S Leung; R L Coppel; A Ansari; Y Nakanuma; M E Gershwin
Journal:  Hepatology       Date:  1997-04       Impact factor: 17.425

8.  Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice.

Authors:  J E Merrill; D H Kono; J Clayton; D G Ando; D R Hinton; F M Hofman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-15       Impact factor: 11.205

9.  Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients.

Authors:  B Portmann; H Popper; J Neuberger; R Williams
Journal:  Gastroenterology       Date:  1985-06       Impact factor: 22.682

10.  Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity.

Authors:  B Richardson; D Powers; F Hooper; R L Yung; K O'Rourke
Journal:  Arthritis Rheum       Date:  1994-09
View more
  1 in total

1.  Leukotoxin kills rodent WBC by targeting leukocyte function associated antigen 1.

Authors:  Kristina M DiFranco; Rajesh H Kaswala; Chandni Patel; Chinnaswam Kasinathan; Scott C Kachlany
Journal:  Comp Med       Date:  2013-08       Impact factor: 0.982

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.